Location: Atlanta, GA
CIK: 0002077247 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $437M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PCVX | VAXCYTE INC | 662,470 | $38.5M | 8.8% | $44.73 | +18.0% | COM | 92243G108 |
| DFTX | DEFINIUM THERAPEUTICS INC | 1,738,110 | $32.85M | 7.5% | $16.29 | 0.0% | COM SHS | 24477V105 |
| LBRX | LB PHARMACEUTICALS INC | 1,319,362 | $32.54M | 7.5% | $17.47 | +28.1% | COM SHS | 50180M108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 333,312 | $30.79M | 7.1% | $94.20 | +2.5% | COM | 604749101 |
| NRIX | NURIX THERAPEUTICS INC | 1,743,220 | $27.02M | 6.2% | $14.37 | +20.7% | COM | 67080M103 |
| XENE | XENON PHARMACEUTICALS INC | 440,000 | $25.59M | 5.9% | $42.00 | -0.0% | COM | 98420N105 |
| RVMD | REVOLUTION MEDICINES INC | 245,000 | $23.83M | 5.5% | $103.02 | 0.0% | COM | 76155X100 |
| RCUS | ARCUS BIOSCIENCES INC | 1,047,935 | $22.64M | 5.2% | $20.51 | +3.7% | COM | 03969F109 |
| IMCR | IMMUNOCORE HLDGS PLC | 682,597 | $20.58M | 4.7% | $34.71 | — | ADS | 45258D105 |
| CYTK | CYTOKINETICS INC | 300,000 | $19.77M | 4.5% | $64.44 | 0.0% | COM NEW | 23282W605 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 701,821 | $16.39M | 3.8% | $20.76 | 0.0% | COM | 87164F105 |
| NGNE | NEUROGENE INC | 782,787 | $15.78M | 3.6% | $24.89 | -27.1% | COM | 64135M105 |
| IVA | INVENTIVA SA | 2,657,997 | $14.75M | 3.4% | $4.65 | — | ADS | 46124U107 |
| IKT | INHIBIKASE THERAPEUTICS INC | 8,057,345 | $13.54M | 3.1% | $1.62 | +6.8% | COM NEW | 45719W205 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1,302,917 | $12.13M | 2.8% | $8.57 | 0.0% | COM | 35104E100 |
| XENE | XENON PHARMACEUTICALS INC | 200,000 | $11.63M | 2.7% | $42.00 | -0.0% | Put | 98420N105 |
| XFOR | X4 PHARMACEUTICALS INC | 2,571,478 | $10.62M | 2.4% | $3.63 | +0.1% | COM NEW | 98420X202 |
| IMVT | IMMUNOVANT INC | 414,054 | $10.29M | 2.4% | $23.96 | +9.6% | COM | 45258J102 |
| DSGN | DESIGN THERAPEUTICS INC | 852,013 | $9.065M | 2.1% | $9.99 | 0.0% | COM | 25056L103 |
| CAMP | CAMP4 THERAPEUTICS CORP | 1,939,563 | $8.553M | 2.0% | $4.25 | +9.7% | COM | 13463J101 |
| NERV | MINERVA NEUROSCIENCES INC | 1,419,000 | $8.549M | 2.0% | $4.97 | 0.0% | COM NEW | 603380205 |
| PMN | PROMIS NEUROSCIENCES INC | 557,103 | $7.075M | 1.6% | $12.16 | 0.0% | COM SHS | 74346M505 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 85,496 | $6.773M | 1.6% | $66.40 | 0.0% | SHS NEW | M8694L137 |
| IPSC | CENTURY THERAPEUTICS INC | 2,449,993 | $5.537M | 1.3% | $1.94 | 0.0% | COM | 15673T100 |
| VTVT | VTV THERAPEUTICS INC | 139,578 | $5.536M | 1.3% | $27.73 | +30.3% | CL A NEW | 918385204 |
| SNSE | SENSEI BIOTHERAPEUTICS INC | 125,000 | $3.94M | 0.9% | $13.96 | 0.0% | COM NEW | 81728A207 |
| IRD | OPUS GENETICS INC | 500,000 | $2.275M | 0.5% | $2.74 | 0.0% | COM | 67577R102 |